Literature DB >> 2536903

Dynamics of the multidomain fibrinolytic protein urokinase from two-dimensional NMR.

R E Oswald1, M J Bogusky, M Bamberger, R A Smith, C M Dobson.   

Abstract

The recent demonstrations that thrombolytic therapy with plasminogen activators can result in substantial reductions in mortality from coronary thrombosis have generated considerable interest in the properties of fibrinolytic enzymes. Examination of the primary sequence of these proteins (which include tissue plasminogen activator, plasminogen, and urokinase) reveals that each is composed of a mosaic of domains which appear to be spatially distinct and connected by short peptide linkers. There is, however, little experimental information about the three-dimensional structure of any of the proteins, although several X-ray diffraction and NMR studies of isolated domains have been reported. Here we report two-dimensional NMR spectra of intact urokinase which are remarkably well resolved for a protein of this molecular weight. This effect is a consequence of substantial independent motion between individual domains of the protein, which overcomes the broadening effects anticipated for the slow overall tumbling rate of the intact molecule. As well as having significance for the physiological role of the protein, these results provide a direct means for the comparison of structural features determined for the isolated domains with those of the intact protein and may provide a basis for proposing or evaluating models for the overall structure of fibrinolytic proteins. Preliminary results with other proteins indicate that this approach may be generally applicable to other multidomain proteins of the fibrinolytic family.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2536903     DOI: 10.1038/337579a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  9 in total

1.  1H-n.m.r. studies of the fibronectin 13 kDa collagen-binding fragment. Evidence for autonomous conserved type I and type II domain folds.

Authors:  K L Constantine; S A Brew; K C Ingham; M Llinás
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

2.  Antigen mobility in the combining site of an anti-peptide antibody.

Authors:  J C Cheetham; D P Raleigh; R E Griest; C Redfield; C M Dobson; A R Rees
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain.

Authors:  A Jasanoff; S J Park; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

4.  Characterization of structural and folding properties of streptokinase by n.m.r. spectroscopy.

Authors:  A J Teuten; R W Broadhurst; R A Smith; C M Dobson
Journal:  Biochem J       Date:  1993-03-01       Impact factor: 3.857

5.  2D NMR of paramagnetic metalloenzymes: cyanide-inhibited horseradish peroxidase.

Authors:  J S de Ropp; L P Yu; G N La Mar
Journal:  J Biomol NMR       Date:  1991-07       Impact factor: 2.835

6.  Uptake of Al3+ into the N-lobe of human serum transferrin.

Authors:  G Kubal; A B Mason; P J Sadler; A Tucker; R C Woodworth
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

7.  Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.

Authors:  P H Jensen; E I Christensen; P Ebbesen; J Gliemann; P A Andreasen
Journal:  Cell Regul       Date:  1990-12

8.  Phosphorylation of human pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adherence and motility.

Authors:  P Franco; C Iaccarino; F Chiaradonna; A Brandazza; C Iavarone; M R Mastronicola; M L Nolli; M P Stoppelli
Journal:  J Cell Biol       Date:  1997-05-05       Impact factor: 10.539

9.  Investigating the mechanisms of amylolysis of starch granules by solution-state NMR.

Authors:  Andrew J Baldwin; Danielle L Egan; Fredrick J Warren; Paul D Barker; Christopher M Dobson; Peter J Butterworth; Peter R Ellis
Journal:  Biomacromolecules       Date:  2015-04-14       Impact factor: 6.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.